1
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Campylobacter pylori and gastroduodenal disease

Is there a relationship?

, MB, ChB, MRCP, , MBBS, MRCP & , MD, PhD, FRCP
Pages 31-41 | Published online: 17 May 2016

References

  • Warren JR. Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983: 1 (June 4): 1273
  • Jones DM, Eldridge J, Fox AJ, et al. Antibody to the gastric Campylobacter-like organism (Campylobacter pylortdis)—clinical correlations and distribution in the normal population. J Med Microbiol 1986: 22(1): 57–62
  • Pambianco DJ, Dye KR, Marshall BJ. et al. Gastritis In the rectum: Campylobacter-like organisms in heterotopic inflamed gastric mucosa. Gastroenterology 1988: 94: A340
  • Vaira D, D'Anastasio CD, Holton J, et al. Campylobacter pylori in abattoir workers: Is it a zoonosis? Lancet 1988: 2(8613): 725–6
  • Hazell SL, Lee A, Brady L, et al. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 1986: 153(4): 658–63
  • Goodwin CS, Armstrong JA, Marshall BJ. Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol 1986: 39(4): 353–65
  • Leunk RD, Johnson PT, David BC, et al. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol 1988: 26(2): 93–9
  • Hazell SL, Lee A. Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers. Lancet 1986: 2(8497): 15–7
  • Baskerville A, Newell DG. Naturally occurring chronic gastritis and C pylori infection in the rhesus monkey: a potential model for gastritis in man. Gut 1988: 29(4): 465–72
  • Marshall BJ, Armstrong JA, McGechie DB, et al. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 1987: 142(8): 436–9
  • Morris A, Nicholson G. Ingestion of Campylobacter pyloridls causes gastritis and raises fasting gastric pH. Am J Gastroenterol 1987: 82(3): 192–9
  • Blaser MJ. Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology 1987: 93(2): 371–83
  • Coghlan JG, Gilligan D, Humphries H, et al. Campylobacter pylori and recurrence of duodenal ulcers—a 12-month follow-up study. Lancet 1987: 2(8568): 1109–11
  • Shallcross TM, Rathbone BJ, Heatley RV. Campylobacter pylori and non-ulcer dyspepsia. In: Rathbone BJ, Heatly RV, eds. Campylobacter pylori and gastroduodenal disease. St Louis: CV Mosby (Blackwell Scientific). 1989: 155–66
  • Rokkas T, Pursey C, Uzoechina E, et al. Campylobacter pylori and non-ulcer dyspepsia. Am J Gastroenterol 1987: 82(11): 1149–52
  • Wyatt JI, Dixon MF. Chronic gastritis—a pathogenetic approach. J Pathol 1988: 154(2): 113–24
  • Goodwin CS, Blincow ED, Warren JR, et al. Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol 1985: 38(10): 1127–31
  • Wyatt JI, Rathbone BJ, Heatley RV. Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol 1986: 39(8): 863–70
  • Bell GD, Weil J, Harrison G, et al. 14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. (Letter) Lancet 1987: 1(8546): 1367–8
  • Goodwin CS, Blake P, Blincow E. The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. J Antimicrob Chemother 1986: 17(3): 309–14
  • McNulty CA, Gearty JC, Crump B, et al. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. BMJ (Clin Res) 1986: 293(6548): 645–9
  • Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984: 1(8390): 1311–5
  • McKinlay AW, Upadhyay R, Boothman P, et al. Study to investigate the clearance of Campylobacter pylori by five preparations containing bismuth. In: Gastroduodenal disease and Campylobacter pylori: proceedings of the European Campylobacter Study Group, Bordeaux. New York: Elsevier Science Publishing (In press)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.